Oertel R, Berndt A, Kirch W
Institute of Clinical Pharmacology, Medical Faculty Carl Gustav Carus, Technical University Dresden, Germany.
Reg Anesth. 1996 Nov-Dec;21(6):576-81.
The amide-type local anesthetic articaine is unique in that hydrolysis to articainic acid by serum esterases is its main metabolic pathway. The purpose of the present investigation was to study the concentration dependence of this pathway in vitro.
To unbuffered (pH 8.2) as well as phosphate-buffered (pH 7.4) heated serum samples were added various amounts of articaine in the range 10-300 micrograms/mL. Concentrations of articaine and articainic acid were measured by high-performance liquid chromatography after incubating the samples at 37 degrees C for intervals ranging from 5 minutes to 6 hours after addition of articaine.
The in vitro metabolism of articaine was shown to undergo pH-dependent Michaelis-Menten kinetics, indicating saturation at higher substrate concentrations. The Michaelis constant K(m) was determined as 175 micrograms/mL and 22.1 micrograms/mL and the maximum reaction rate Vmax as 2.1 micrograms/mL/min and 0.17 microgram/mL/min at pH 8.2 and pH 7.2, respectively. These results support previous in vivo observations that suggest saturable articaine metabolism, indicated by higher articaine/articainic acid metabolic ratio with higher articaine concentrations in alveolar blood after dental extraction.
Local saturation of the serum esterases may contribute to the advantageous relationship between persistence of the local anesthetic effect and low systemic toxicity caused by the last systemic elimination of articaine (ie, its wide toxic therapeutic ratio).
酰胺型局部麻醉药阿替卡因的独特之处在于,其主要代谢途径是被血清酯酶水解为阿替卡因酸。本研究的目的是在体外研究该途径的浓度依赖性。
向未缓冲(pH 8.2)以及磷酸盐缓冲(pH 7.4)的加热血清样本中加入10 - 300微克/毫升范围内的不同量阿替卡因。在加入阿替卡因后,将样本在37℃孵育5分钟至6小时,然后通过高效液相色谱法测量阿替卡因和阿替卡因酸的浓度。
阿替卡因的体外代谢显示出pH依赖性米氏动力学,表明在较高底物浓度下会饱和。在pH 8.2和pH 7.2时,米氏常数K(m)分别测定为175微克/毫升和22.1微克/毫升,最大反应速率Vmax分别为2.1微克/毫升/分钟和0.17微克/毫升/分钟。这些结果支持了先前的体内观察结果,即提示阿替卡因代谢存在饱和性,拔牙后肺泡血中阿替卡因浓度较高时,阿替卡因/阿替卡因酸代谢比更高即表明了这一点。
血清酯酶的局部饱和可能有助于局部麻醉作用的持续时间与阿替卡因最后全身消除所导致的低全身毒性之间的有利关系(即其较大的治疗毒性比)。